Welcome to our dedicated page for Columbia Financ SEC filings (Ticker: CLBK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Columbia Financial, Inc. (NASDAQ: CLBK), the mid-tier holding company for Columbia Bank. Through these filings, investors can review detailed disclosures on the company’s financial condition, results of operations, capital management, and significant corporate events.
Columbia Financial, Inc. uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly earnings releases, including financial results for periods ended March 31, June 30, and September 30, as well as the year ended December 31. These filings typically reference press releases furnished as exhibits that discuss net interest income, interest expense on deposits and borrowings, provision for credit losses, non-interest income and expense, net interest margin, and overall net income or loss.
Other 8-K filings describe corporate actions and governance matters. For example, the company has filed 8-Ks regarding authorization of a stock repurchase program to acquire up to 1,800,000 shares of common stock, including details on regulatory non-objection, permitted repurchase methods, and program terms. Additional 8-Ks disclose executive officer changes, such as the planned end date of employment for a Senior Executive Vice President and Chief Operating Officer, and the availability of investor presentations outlining operating and growth strategies.
Annual reports on Form 10-K and quarterly reports on Form 10-Q, when accessed alongside these current reports, provide comprehensive information on Columbia Financial, Inc.’s loan portfolio composition, deposit base, funding sources, balance sheet repositioning transactions, asset quality metrics, and risk factors. These filings also describe the company’s structure as a Delaware corporation and majority-owned subsidiary of Columbia Bank, MHC, and its role as the holding company for Columbia Bank, a federally chartered savings bank headquartered in Fair Lawn, New Jersey.
Stock Titan’s platform enhances these filings by delivering real-time updates from the SEC’s EDGAR system and AI-powered summaries that highlight key points from lengthy documents. Users can quickly identify important information in 10-K and 10-Q reports, track material events reported on Form 8-K, and review disclosures related to capital actions such as stock repurchase programs. Insider transaction reports on Form 4, where available, can also be monitored to see reported purchases and sales by directors and executive officers.
By combining Columbia Financial, Inc.’s official SEC filings with AI-generated insights, this page helps readers understand how the company describes its performance, strategy, and risk profile in its own regulatory disclosures.
Columbia Financial, Inc. (CLBK) – Form 4 filed 29 Jul 2025
Senior EVP & Head of Consumer Banking Allyson Katz Schlesinger disclosed a modest insider purchase on 25 Jul 2025. She acquired 23.7825 phantom common-stock units at $14.07 each through the Columbia Bank Stock-Based Deferral Plan; no shares were sold.
Updated ownership:
- 13,301.1567 shares held indirectly via the Deferral Plan (new total)
- 64,281 shares held directly
- 39,575 shares held indirectly via ESOP, SERP, SIM and performance-based Stock Awards II–IV
- 198,507 stock options exercisable between $15.60–$16.49, expiring 2029-2035
On 11 July 2025, Columbia Financial, Inc. (ticker CLBK) director Elizabeth E. Randall filed a Form 4 reporting a modest increase in her indirect ownership.
- Transaction: 166.4981 common shares were automatically purchased through the company’s Stock-Based Deferral Plan at $14.82 per share.
- Post-transaction holdings: 9,174.0827 shares in the Deferral Plan. Including prior positions, the director now controls roughly 103,266 shares spread across direct (39,934), IRA (44,447), Roth IRA (6,704) and unvested stock-award (3,207) accounts.
- Derivative position: 62,474 fully-vested stock options with a $15.60 strike price expiring 23 July 2029 remain unchanged.
No shares were sold in the reporting period, resulting in a net purchase that marginally increases insider exposure to CLBK equity. The filing was signed on 15 July 2025 by attorney-in-fact Dennis E. Gibney.